Harbor Spring Capital’s Elevance Health ELV Stock Holding History

Harbor Spring Capital’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-72,000	Closed	-$35.4M	–	21
2022 Q1	$35.4M	Buy	72,000 +10,500	+17%	+$4.8M	5.67%	6
2021 Q4	$28.5M	Sell	61,500 -7,500	-11%	-$3.16M	3.25%	15
2021 Q3	$25.7M	Hold	69,000	–	–	1.81%	21
2021 Q2	$26.3M	Buy	+69,000	New	+$26.4M	1.79%	18

Other funds holding ELV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return

Harbor Spring Capital's ELV Position: Q2 2022 in Review

Harbor Spring Capital sold out of Elevance Health (ELV) in Q2 2022, closing a stake of 72,000 shares — an estimated $35.4M sold.

Harbor Spring Capital first reported a position in ELV in Q2 2021 and held it in 4 quarters. The position peaked at $35.4M in Q1 2022. 1,442 funds tracked by Wall St. Rank hold ELV as of Q2 2022.

Harbor Spring Capital reported no remaining Elevance Health position as of Q2 2022 after selling out during the quarter.
Harbor Spring Capital sold 72,000 Elevance Health shares in Q2 2022, an estimated $35.4M.
Harbor Spring Capital first reported a position in Elevance Health in Q2 2021 and held it in 4 quarters.
Harbor Spring Capital's Elevance Health position peaked at $35.4M in Q1 2022.
1,442 funds tracked by Wall St. Rank held Elevance Health as of Q2 2022.

Based on Harbor Spring Capital's 13F filing for Q2 2022, filed 12 Aug 2022.